Victory Portfolios II - VictoryShares US EQ Income Enhanced Volatility Wtd ETF Past Earnings Performance
Past criteria checks 0/6
There is insufficient data on Victory Portfolios II - VictoryShares US EQ Income Enhanced Volatility Wtd ETF's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Capital Markets Industry Growth | 10.3% |
Revenue growth rate | n/a |
Return on equity | n/a |
Net Margin | n/a |
Earnings Update | n/a |
Recent past performance updates
No updates
Recent updates
CDC: Revisiting This Once Top-Performing High-Dividend ETF
Mar 14CDC: 4% Estimated Yield And A Check-Up After September's Reconstitution
Sep 28CDC: High-Yield Low-Volatility Equity Index ETF, Complicated Strategy, Strong Performance
Aug 04CDC: Testing The Long/Cash Low Volatility Strategy Over 20 Years
Jul 14CDC: Volatility-Weighted Dividend Strategy Delivering Alpha In 2022
May 09CDC: Three Layers Of Portfolio Protection
Feb 18CDC: Like Medicine For Market Corrections
Jun 16In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, Victory Portfolios II - VictoryShares US EQ Income Enhanced Volatility Wtd ETF has not provided sufficient past data to assess its track record.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.
Show sectionRevenue & Expenses BreakdownBeta
How Victory Portfolios II - VictoryShares US EQ Income Enhanced Volatility Wtd ETF makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|
Quality Earnings: Insufficient data to determine if CDC has high quality earnings.
Growing Profit Margin: Insufficient data to determine if CDC's profit margins have improved over the past year.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Unable to establish if CDC's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.
Accelerating Growth: Unable to compare CDC's past year earnings growth to its 5-year average as it has been trading publicly for less than 3 years.
Earnings vs Industry: Insufficient data to determine if CDC's earnings growth over the past year exceeded the Capital Markets industry average.
Return on Equity
High ROE: CDC has a negative Return on Equity (0%), as it is currently unprofitable.